Cigna Sets Long-Term Goals, Unveils 2030 Modernization Strategy

The Cigna Group (NYSE:CI) presented its “Lead to One” strategic growth framework at its Investor Day on Wednesday, detailing long-term plans to transform healthcare by improving affordability and customer personalization. Driving Core Growth Across Healthcare Platforms The company’s strategic framework centers on driving core portfolio expansion, leveraging distinct clinical capabilities, and maintaining operational discipline. Its core platforms—comprising Cigna Healthcare alongside Evernorth’s Specialty & Care Services and Pharmacy Benefit Services—share clinical expertise, data, customer relationships, and distribution channels. These connected assets allow the enterprise to capture expanding share across growing, high-value segments of the healthcare market. Read Also: Independent Pharmacies Accuse Prime Therapeutics of Price-Fixing Scheme With Express Scripts Reaffirming Guidance and Setting 2030 Financial Targets The enterprise reaffirmed its 2026 financial outlook, targeting consolidated adjusted revenues of approximately $280 billion and consolidated adjusted earnings per share of at least $30.45 versus consensus of $30.41. Divisionally, Evernorth Health Services projects pre-tax adjusted operating income of at least $6.90 billion, Cigna Healthcare targets at least $4.55 billion, and the consolidated medical care ratio remains expected to be between 83.7% and 84.7%. For the 2026 to 2030 period, management announced financial targets including a 10% to 14% adjusted EPS compound annual growth rate and roughly $50 billion in cumulative operating cash flow. The enterprise also launched a new $3 billion multi-year modernization and productivity initiative aimed at streamlining workflows, applying artificial intelligence tools, and optimizing vendor management. Navigating Clinical Complexity With Advanced Capabilities To manage complex patient care, which often involves multiple diagnoses, specialty medications, behavioral health, and primary care navigation, the enterprise engages patients across more of their treatment journey. Evernorth Specialty & Care Services supports over one million patients with complex conditions and delivers more than eight million prescriptions annually. Meanwhile, Cigna Healthcare provides proactive experiences such as early oncology identification and artificial intelligence-enabled advocacy. At the same time, Evernorth Pharmacy Benefit Services combines clinical insights with supply chain expertise to lower costs and boost treatment adherence. CI Price Action: Cigna Group shares were down 0.44% at $274.04 at the time of publication on Wednesday, according to Benzinga Pro data. Read Also: Anthropic Just Hired a Google Project Zero Veteran To Lead Its Frontier AI Red Team Photo: Shutterstock